IP

International Paper

$41.34

-0.58%
Aug 10, 2026
Bobby Quantitative Model
International Paper Co. is a leading global manufacturer of renewable fiber-based packaging and pulp products, serving industrial, consumer, and manufacturing end markets. The company commands a dominant position in the North American corrugated packaging market, accounting for roughly one-third of the market, and has expanded its European footprint through the acquisition of DS Smith. Currently, the stock is under scrutiny as the company navigates the integration of DS Smith, faces cyclical headwinds in packaging demand, and manages a significant debt load, while recent strategic moves like the NORPAC mill acquisition signal a focus on strengthening its West Coast presence.

People also watch

UFP Industries, Inc. Common Stock

UFP Industries, Inc. Common Stock

UFPI

Analysis
Louisiana-Pacific

Louisiana-Pacific

LPX

Analysis
Southern Copper Corporation

Southern Copper Corporation

SCCO

Analysis
Newmont Mining Corporation

Newmont Mining Corporation

NEM

Analysis
Freeport-McMoRan

Freeport-McMoRan

FCX

Analysis

BobbyInvestment Opinion: Should I buy IP Today?

Rating: Hold. International Paper is a cyclical value play with a consensus Buy rating and an average price target of $47.45, implying 17% upside. However, the negative profitability and high debt make it a risky investment. The thesis is that the company's strategic acquisitions and cost synergies will drive a recovery, but this is not yet evident in the financials.

Sign up to view all

IP 12-Month Price Forecast

The AI assessment is neutral with medium confidence. The stock is undervalued on a PS basis, but the negative profitability and high debt create significant risk. The forward estimates suggest a strong recovery, but this is not yet visible in the trailing data. The stock could be a good value play if the turnaround materializes, but the risk of further downside is real. Upgrades to bullish would require evidence of margin expansion and positive EPS, while downgrades to bearish would occur if revenue growth turns negative or the dividend is cut.

Historical Price
Current Price $41.34
Average Target $47.50
High Target $61.00
Low Target $29.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on International Paper's 12-month outlook, with a consensus price target around $47.45 and implied upside of +14.8% versus the current price.

Average Target

$47.45

0 analysts

Implied Upside

+14.8%

vs. current price

Analyst Count

covering this stock

Price Range

$39 - $61

Analyst target range

International Paper has coverage from 11 analysts, with a consensus recommendation of 'Buy' and a mean rating of 1.83 (where 1 is Strong Buy and 5 is Sell). The average price target is $47.45, implying an upside of 17.1% from the current price of $40.53. The distribution includes 6 Buy ratings, 4 Hold/Neutral ratings, and 1 Sell rating, reflecting a generally bullish but cautious sentiment. Recent actions show no major downgrades, with firms like Truist Securities reiterating Buy and Wells Fargo upgrading from Equal Weight to Overweight in May 2026.

Drowning in data?

Find the real signal!

Bulls vs Bears: IP Investment Factors

International Paper presents a classic value-recovery scenario: deeply discounted valuation (PS 0.84x vs. industry 1.5x) and a consensus Buy rating with 17% upside, but weighed down by negative profitability, high debt, and sluggish revenue growth. The bull case hinges on successful integration of DS Smith and NORPAC, leading to margin expansion and earnings recovery, while the bear case centers on continued cyclical weakness and the risk of further write-downs. Currently, the evidence slightly favors the bulls given the low valuation and analyst optimism, but the key tension is whether the company can translate its strategic moves into sustainable profitability. If margins recover as expected, the stock could re-rate significantly; if not, the debt burden and operational losses could deepen the downside.

Bullish

  • Deep valuation discount to peers: IP trades at a price-to-sales ratio of 0.84x, a 44% discount to the industry average of 1.5x. This suggests the market is pricing in significant pessimism, offering potential upside if the company executes its turnaround.
  • Analyst consensus is Buy with 17% upside: The average analyst price target is $47.45, implying a 17.1% upside from the current price of $40.53. With 6 Buy ratings and only 1 Sell, sentiment is cautiously optimistic, and recent upgrades (e.g., Wells Fargo) reinforce this view.
  • Strategic acquisitions bolster growth: The $360 million NORPAC acquisition strengthens IP's West Coast presence, while the DS Smith acquisition expands its European footprint. These moves position the company to capture growth in packaging demand and diversify revenue streams.
  • Forward earnings imply strong recovery: Analysts estimate forward EPS of $3.86, which would put the forward PE at 13.79x. This is a reasonable multiple for a cyclical recovery, and if achieved, would represent a dramatic improvement from the current negative trailing EPS of -$0.17.

Bearish

  • Negative profitability and high debt: IP's trailing twelve-month net income is negative (EPS -$0.17), and the debt-to-equity ratio is 0.73. The company's high debt load, partly from the DS Smith acquisition, increases financial risk and limits flexibility.
  • Revenue growth is sluggish: Q1 2026 revenue grew only 1.19% YoY, and the multi-quarter trend shows deceleration from Q2 2025's $6.77B to Q4 2025's $6.01B. This suggests weak end-market demand, particularly in packaging, which is cyclical.
  • Stock underperforms market significantly: IP's 1-year price change is -12.52% versus the S&P 500's +21.46%, a relative underperformance of nearly 34 percentage points. This reflects persistent bearish sentiment and a lack of investor confidence in the turnaround.
  • High short interest and negative margins: The short ratio is 8.92, indicating elevated bearish positioning. Additionally, operating margin is -11.3% and net margin is -14.1%, showing that the company is currently unprofitable at the operational level.

IP Technical Analysis

International Paper's stock has been in a clear downtrend over the past year, with a 1-year price change of -12.52%, significantly underperforming the S&P 500's +21.46% gain. The current price of $40.53 sits at 80.6% of its 52-week range (low $29.26, high $50.25), indicating the stock has recovered from its lows but remains well below its highs. This positioning suggests a potential value opportunity if the recovery continues, but also reflects lingering bearish sentiment from the prolonged decline.

Beta

0.89

0.89x market volatility

Max Drawdown

-47.2%

Largest decline past year

52-Week Range

$29-$50

Price range past year

Annual Return

-13.1%

Cumulative gain past year

PeriodIP ReturnS&P 500
1m+9.0%+2.4%
3m+25.8%+4.7%
6m-16.0%+11.7%
1y-13.1%+21.3%
ytd+2.7%+13.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

IP Fundamental Analysis

Revenue has shown modest growth, with the most recent quarter (Q1 2026) reporting $5.971 billion, a 1.19% YoY increase. However, the multi-quarter trend is mixed: Q2 2025 revenue was $6.767 billion, Q3 2025 was $6.222 billion, and Q4 2025 was $6.006 billion, indicating a deceleration before the slight uptick in Q1 2026. The company's revenue segments show North America Packaging Solutions as the largest contributor at $3.702 billion, followed by EMEA at $1.55 billion, and Global Cellulose Fibers at $643 million, with the EMEA segment benefiting from the DS Smith acquisition.

Quarterly Revenue

$6.0B

2026-03

Revenue YoY Growth

+1.2%

YoY Comparison

Gross Margin

20.7%

Latest Quarter

Free Cash Flow

$553000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Global Cellulose Fibers
Packaging Solutions EMEA
Packaging Solutions North America

Open an Account, get $2 TSLA now!

Valuation Analysis: Is IP Overvalued?

Given that International Paper's trailing twelve-month net income is negative (EPS of -$0.17), the price-to-sales (PS) ratio is the most appropriate valuation metric. The current PS ratio is 0.84x, which is significantly lower than the industry average of 1.5x, indicating a 44% discount. This discount is justified by the company's negative profitability and high debt levels, but it also suggests the market is pricing in a recovery. The forward PE of 13.79x implies that analysts expect earnings to rebound strongly, with estimated EPS of $3.86 for the next fiscal year.

PE

-5.9x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range 3x~81x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-220.7x

Enterprise Value Multiple

Investment Risk Disclosure

Financial risks are substantial: IP's trailing net income is negative (EPS -$0.17), and the company carries a debt-to-equity ratio of 0.73, reflecting the leverage from the DS Smith acquisition. Interest expenses were $132 million in Q1 2026, and with negative operating margins (-11.3%), the company is not generating enough operational profit to cover its debt service comfortably. The negative free cash flow (TTM FCF of $553 million is positive, but this is after heavy capital expenditures) and the high payout ratio (negative due to losses) indicate financial strain. If the integration of DS Smith fails to deliver expected synergies, the company may face liquidity pressures or be forced to cut its dividend (current yield 4.7%).

FAQ

The key risks are: 1) Financial risk: high debt (debt-to-equity 0.73) and negative profitability (EPS -$0.17) could lead to financial distress if not addressed. 2) Operational risk: the integration of DS Smith and NORPAC may fail to deliver expected synergies, leading to continued losses. 3) Market risk: the packaging industry is cyclical, and a downturn could reduce demand and revenue. 4) Company-specific risk: the stock has underperformed the market by 34 percentage points over the past year, indicating persistent negative sentiment. The most severe risk is a combination of these factors, which could push the stock to its 52-week low of $29.26, a 28% downside.

The 12-month forecast for IP is mixed. In the base case (45% probability), the stock trades around $45-50, in line with the analyst average target of $47.45. In the bull case (30% probability), the stock could reach $50-61 if the turnaround succeeds and margins improve. In the bear case (25% probability), the stock could fall to $29-35 if the company fails to integrate acquisitions and demand weakens. The most likely scenario is the base case, which assumes gradual improvement in financial performance. Investors should watch for earnings reports and integration updates to gauge which scenario is unfolding.

IP is undervalued based on its price-to-sales ratio of 0.84x, which is 44% below the industry average of 1.5x. This suggests the market is pricing in significant pessimism about the company's future. However, the negative trailing EPS and high debt justify some discount. The forward PE of 13.79x implies that analysts expect a strong earnings recovery, which, if achieved, would make the stock fairly valued. Compared to its own history, the stock is trading near the lower end of its valuation range, indicating a potential value opportunity. The market is expecting a turnaround, and if that fails, the stock could be overvalued.

IP is a good buy for investors who believe in the turnaround story and are willing to tolerate volatility. The stock trades at a 44% discount to its industry on a PS basis, and analysts see 17% upside to the average target of $47.45. However, the company is currently unprofitable, with a negative EPS of -$0.17, and carries a high debt load. The risk-reward is skewed to the upside if the integration of DS Smith and NORPAC succeeds, but the downside to the 52-week low of $29.26 is 28%. For value investors with a long-term horizon, it could be a good buy, but for risk-averse investors, it may be better to wait for evidence of profitability.

IP is more suitable for long-term investment, given its cyclical nature and turnaround status. The stock has a beta of 0.894, indicating moderate volatility, and the 1-year price change of -12.5% shows significant short-term risk. The company's dividend yield of 4.7% provides income while waiting for the recovery, but the negative earnings make the payout risky. For long-term investors (3-5 years), the deep valuation discount and potential for earnings growth could offer substantial returns. Short-term traders may find opportunities in the volatility, but the stock's direction is uncertain. A minimum holding period of 3 years is recommended to allow the integration benefits to materialize.